The University of Manchester has appointed Professor Aline Miller as the new Chief Scientific Officer of Unit M. The newly launched innovation capability based at the University is aimed at fostering connections between the University and the regional innovation ecosystem to promote inclusive growth.
Unit M is dedicated to tackling the full spectrum of innovation challenges – from research and development to innovation adoption, as well as talent and skills development. By enhancing access to the University’s world-class research, innovation resources, and expertise, it seeks to address critical regional and national issues, including productivity, innovation uptake, and economic inclusivity.
Professor Miller will take up her role as Chief Scientific Officer immediately within the newly formed leadership team. “I am thrilled to take on the role of Chief Scientific Officer for Unit M. I am passionate about generating tangible impact from our teaching, research and social responsibility activities.” Said Aline. “I look forward to working with our students, staff and external partners to unlock innovation growth opportunities to maximise the University’s impact on our region’s economy and society.”
Aline is Professor of Biomolecular Engineering and Associate Dean for Business Engagement and Innovation within the Faculty of Science and Engineering at The University of Manchester. She is Director of the NW Industrial Biotechnology Innovation Catalyst – a £5m flagship programme supercharging the growth of careers, business and the regional economy, while delivering sustainable products and processes.
Aline’s academic achievements to date have earned her several notable awards, including recognition from the Royal Academy of Engineering, Women in Engineering, The Leverhulme Trust, and the Great British Entrepreneur Awards. Aline has also developed an impressive track record of securing funding and translating academic research into commercial and clinical applications through collaborations with a range of industry partners, from SMEs to large corporations.
She also co-founded a spin-out company, Manchester BIOGEL, which, under her leadership as CEO, secured over £4M in investment from Innovate UK, venture capital, private investors, and Catapult Venture Funds. The company grew to a team of 10, became revenue-generating, and achieved significant recognition, being listed among the Top 10 Biotech Start-Ups in Europe by Start-Up City in 2021 and winning Best New Life Science Product 2021. In 2023, Manchester BIOGEL successfully navigated an exit, with its technology being acquired by Cell Guidance Systems Ltd.
The announcement follows the recent appointment of Professor Lou Cordwell as CEO of Unit M.
Lou said: “We’re thrilled to welcome Aline into the founding Unit M team. Her leadership experience both in her field and as a founder will be invaluable, alongside her passion for growing the calibre and profile of the region’s start-up ecosystem.”
Unit M is now live and actively engaging with entrepreneurs, investors, and changemakers eager to shape the future of the region.
For more information about Unit M and partnership opportunities, visit
